搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
The Financial Express
9 小时
Glaucoma market to grow to $2.5 billion in seven major markets by 2033, reveals report
GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.
1 天
GWM's Hi4 Off-Road Family Takes Over LIWA: A Journey Through Adventure And Innovation
This year's festival brought together off-road enthusiasts, automotive experts, and influencers from across the globe. Amid ...
The Financial Express
2 天
Novartis gene therapy poised to expand SMA treatment landscape
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...
VietNamNet
2 天
Ho Chi Minh City Police issue alert on hidden gambling in “blind bag” trend
Authorities have flagged the popular “blind bag” trend on social media as a form of disguised gambling, with participants ...
The Independent Singapore
2 天
You can eat whatever you want and still lose weight, as long as you are eating in a calorie ...
You can eat sugar, you can eat carbs, you can eat whatever you want on your weight loss journey and still be successful. We ...
来自MSN
2 天
OSCE PA president cancels trip to Tbilisi amid huge backlash
By bne IntelliNews Pia Kauma, the president of the OSCE Parliamentary Assembly (OSCE PA), has postponed a planned delegation ...
4 天
'Never Stopped Eating My Fav Foods': Woman Who Shed 30 Kg Shares 3 Weight Loss Tips
A fitness influencer shared three weight loss strategies to help shed those extra pounds, emphasizing the need for realistic ...
4 天
Woman who shed 32 kg shares 3 weight loss tips inspired by her journey: 'We don't need to ...
A fitness influencer shared 3 weight loss tips to help shed those kilos, stressing the importance of realistic expectations ...
clinicaltrialsarena
6 天
Positive data could expand use of Novartis’ gene therapy for SMA
Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached its primary endpoint in a Phase III study in paediatric patients aged two to 17 with type II ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈